Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
17.59
-0.21 (-1.18%)
Mar 10, 2026, 2:23 PM HKT
-45.03% (1Y)
| Market Cap | 2.42B |
| Revenue (ttm) | 2.34M |
| Net Income (ttm) | -123.26M |
| Shares Out | 136.22M |
| EPS (ttm) | -11.28 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 43,700 |
| Average Volume | 122,974 |
| Open | 18.20 |
| Previous Close | 17.80 |
| Day's Range | 17.03 - 18.20 |
| 52-Week Range | 13.48 - 32.00 |
| Beta | 0.84 |
| RSI | 44.21 |
| Earnings Date | n/a |